As Wall Street experienced losses following Nvidia Corp.’s impressive earnings report, investors were left disappointed. However, this outcome did not come as a surprise to Mike Wilson, Chief Investment Strategist at Morgan Stanley.
Wilson commented in a Bloomberg radio interview that while the rally around artificial intelligence (AI) sparked enthusiasm earlier this year, investors must recognize the significant investment phase required in the short term. Although Morgan Stanley remains bullish on AI in the long run, Wilson believes it is crucial to avoid extrapolating the performance of a few stocks to the broader market.
The recent news from Nvidia, reporting an 88% increase in revenue from the previous quarter and surpassing its own expectations, was met with excitement. However, it ultimately resulted in a failed rally. This failure serves as a negative technical signal, indicating that the rally may be reaching exhaustion.
Looking forward, Wilson states that a fresh and compelling narrative is necessary to reignite investor excitement in the stock market. Earlier this year, the market displayed excessive negativity towards the economy and the possibility of a hard landing. Subsequently, it became oversold in March before swinging to the opposite extreme with a rally fueled by optimistic views.
Wilson cautions against becoming overly optimistic, expressing that the market became excessively overbought in July due to the belief in a soft landing. While it does not foreshadow an impending recession, it does imply higher-than-normal risks compared to regular market conditions.
In summary, Wilson highlights the importance of crafting a new story to captivate investors and boost confidence in stocks once again. The market’s journey this year has been characterized by oscillations between pessimism and optimism, reminding investors of the significance of prudent decision-making amidst changing circumstances.
- Can Nvidia sustain its rapid growth? Wall Street weighs in
- Vanguard identifies attractive valuation for value stocks post-COVID